Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP482567.RAeoQ5yQCYa0ma0wbC9-FKHHIumGFsBbzRT9R5wM2BCB0130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482567.RAeoQ5yQCYa0ma0wbC9-FKHHIumGFsBbzRT9R5wM2BCB0130_provenance.
• NP407103.RAm6vkhXkz7lSzoHh1OzgBgilvqmmUlxExT6I8TgeMn3w130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407103.RAm6vkhXkz7lSzoHh1OzgBgilvqmmUlxExT6I8TgeMn3w130_provenance.
• NP414674.RAfhsT3Aq4PDlRnOBhLtQtYAYx3HisuiS-erX2xwjY37Y130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414674.RAfhsT3Aq4PDlRnOBhLtQtYAYx3HisuiS-erX2xwjY37Y130_provenance.
• NP597899.RAu_bU-sTbNxEQm_i-MBdiCQouYKz1ES0OWCtiGL-nH2g130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP597899.RAu_bU-sTbNxEQm_i-MBdiCQouYKz1ES0OWCtiGL-nH2g130_provenance.
• NP323066.RA3unkULC8zK_l4MBWKmclfIJQ3u1BUOb9dDbiXGUH-j0130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323066.RA3unkULC8zK_l4MBWKmclfIJQ3u1BUOb9dDbiXGUH-j0130_provenance.
• assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP347562.RAVdjr0YorhygtwO1mvOuENEzHJ3CCwT3SzfxvhJizLWc130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347562.RAVdjr0YorhygtwO1mvOuENEzHJ3CCwT3SzfxvhJizLWc130_provenance.
• assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP321208.RAACfI--Twv7b5GAhtfTsjVNmtBvgvOPHZlmtWuqQr55I130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321208.RAACfI--Twv7b5GAhtfTsjVNmtBvgvOPHZlmtWuqQr55I130_provenance.
• NP321215.RADqoc6Y-PzSKbln5PTvdyoaGwmpM4M2FXrRUGvjSyhdQ130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321215.RADqoc6Y-PzSKbln5PTvdyoaGwmpM4M2FXrRUGvjSyhdQ130_provenance.
• NP321214.RAWNafvhCfjQLCGH--1sfiYrP5mpvGEiy3u8zd5mjKVBI130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321214.RAWNafvhCfjQLCGH--1sfiYrP5mpvGEiy3u8zd5mjKVBI130_provenance.
• NP300631.RAlOL9Q0h30KNBYRSaTrX-kWpbGAwg5HxCfqPZgxGl4F0130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300631.RAlOL9Q0h30KNBYRSaTrX-kWpbGAwg5HxCfqPZgxGl4F0130_provenance.
• NP301026.RAtT_VIuDWWMmVKomx5Fh9X_480EHk9r6polPxvrF3Hww130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301026.RAtT_VIuDWWMmVKomx5Fh9X_480EHk9r6polPxvrF3Hww130_provenance.
• NP321206.RApxVdMsOtsgRxaeeQs2oqv6dCdNc5W-xdLoyYzW33okU130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321206.RApxVdMsOtsgRxaeeQs2oqv6dCdNc5W-xdLoyYzW33okU130_provenance.
• NP321216.RAtxim6u0hceC3Ik1w5Rojvq43VQRqeC2j-UoD8PbAHWQ130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321216.RAtxim6u0hceC3Ik1w5Rojvq43VQRqeC2j-UoD8PbAHWQ130_provenance.
• NP347598.RAFiOhrN5MzUoDUKBjpvlLC_rm78U75L4sSbzsUsCH-Xw130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347598.RAFiOhrN5MzUoDUKBjpvlLC_rm78U75L4sSbzsUsCH-Xw130_provenance.
• NP321205.RA9YIjLJnw-E2pWa0ba16upCQKsTLF5YcJW_lycgYWhiA130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321205.RA9YIjLJnw-E2pWa0ba16upCQKsTLF5YcJW_lycgYWhiA130_provenance.
• NP321207.RA_U4-8Je_IRXXOtNnNUNjitXh0GJzdkGmFEqsvYwGuik130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321207.RA_U4-8Je_IRXXOtNnNUNjitXh0GJzdkGmFEqsvYwGuik130_provenance.
• NP321209.RAzQlFMy2iRGTVub7MHmnG0IInMhODggsGw4Hsb4PcaMU130_assertion description "[To better define cytogenetic mechanisms of CDKN2 loss at 9p21 and of DBCCR1 loss at 9q33 in bladder cancer, and to determine correlation with p53 and pRb.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321209.RAzQlFMy2iRGTVub7MHmnG0IInMhODggsGw4Hsb4PcaMU130_provenance.